CORA SHELTON: Open Payments
NPI 1427878487 · LEBANON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
Products named: CAPLYTA, BREZTRI, UBRELVY, TRELEGY ELLIPTA, QULIPTA, Wegovy, VRAYLAR, FARXIGA.
Industry payments across VA — which companies pay providers there.
